Hematoma: Clinical Trials

17 trials for Hematoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 unknown, 4 recruiting, 3 terminated. 17 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 317Completed 5, Unknown 5, Recruiting 4, Terminated 3
Phase 26Recruiting 2, Terminated 2, Unknown 2

Follow Hematoma: new trials by email Literature Review of Hematoma trials Research Report on Hematoma

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma
Tranexamic acid (TXA), Placebo - Subdural Hematoma
Phase 3RecruitingUnity Health Toronto1302026-05-202026-05-29
Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)
Tranexamic Acid (Cyklokapron) - Chronic Subdural Hematoma
Phase 2 / Phase 3RecruitingSt. Olavs Hospital2742025-12-102026-07-17
Prospective Clinical Investigation on Infection as a Cause of Chronic Subdural Hematoma.
Amoxicillin + clavulanic acid, Placebo ( FE) - Chronic Subdural Hematomas
Phase 2 / Phase 3RecruitingUniversity of Rostock1642024-09-012026-04-29
Efficacy of Atorvastatin in Chronic Subdural Haematoma
Atorvastatin 20mg, Placebos - Chronic Subdural Hematoma
Phase 3UnknownChinese University of Hong Kong6902020-01-092021-11-22
Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma
Tranexamic Acid 500Mg Tablet, Placebo oral capsule - Hematoma, Subdural, Chronic
Phase 3RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)5542018-06-192024-06-20
Start or STop Anticoagulants Randomised Trial (SoSTART)
Apixaban, Rivaroxaban, Edoxaban - Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive
Phase 3CompletedUniversity of Edinburgh2032018-03-282022-04-08
Tocilizumab (RoActemra) and Tranexamic Acid (Cyklokapron) Used as Adjuncts to Chronic Subdural Hematoma Surgery
Tranexamic acid and Tocilizumab - Chronic Subdural Hematoma
Phase 2 / Phase 3TerminatedOslo University Hospital3822017-11-282021-10-13
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma
Tranexamic Acid 500 MG - Chronic Subdural Hematoma
Phase 3UnknownUnity Health Toronto602017-03-062017-09-14
Mgt of Chronic Subdural Hematoma Using Dexamethasone
Dexamethasone, Any surgical intervention aim at treating chronic subdural hematoma - Chronic Subdural Hematoma
Phase 2 / Phase 3UnknownUniversity of Calgary3262016-09-172020-07-01
Treatment of Chronic Subdural Hematoma by Corticosteroids
Methylprednisolone, Placebo - Chronic Subdural Hematomas
Phase 3CompletedRennes University Hospital2022016-06-242020-06-09
Preventive EXACYL® on Perioperative Bleeding During Orthognathism of Maxillary Surgery
Tranexamic Acid, saline solution - Peri-operative Hemorrhage or Hematoma, Surgery
Phase 3CompletedUniversity Hospital, Lille1572016-01-032026-04-22
Tranexamic Acid in Chronic Subdural Hematomas
Tranexamic Acid, Placebo - Chronic Subdural Hematoma
Phase 2 / Phase 3UnknownCentre de recherche du Centre hospitalier universitaire de Sherbrooke1302015-11-012023-09-05
Dexamethasone Versus Burr Hole Craniostomy for Symptomatic Chronic Subdural Hematoma
Dexamethasone, Burr Hole Craniostomy - Chronic Subdural Hematoma
Phase 2 / Phase 3TerminatedUniversity of Virginia102014-03-012018-12-11
The Effect of Subdural Drain Placement After Burr Hole Evacuation of Chronic Subdural Haematomas on Recurrence: a Prospective Randomised-controlled Multi-centre Study
Silicon subdural drain placement after burr hole evacuation of chronic subdural hematoma - Chronic Subdural Hematoma, Subdural Drain
Phase 3UnknownKwong Wah Hospital2602013-06-012013-02-07
Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
Dabigatran, Rivaroxaban, Apixaban - Hematoma
Phase 3CompletedOttawa Heart Institute Research Corporation6632013-01-012019-10-07
Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas
oral corticosteroids, placebo - Chronic Intracranial Subdural Hematoma
Phase 3TerminatedUniversity Hospital, Montpellier1622011-07-222026-06-02
Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma
Autologous Platelet-rich plasma (PRP), Evacuation of haematoma - Muscle Injuries
Phase 3CompletedInstitut de Terapia Regenerativa Tissular712009-10-012013-01-10

Narrower conditions

Hematoma, Subdural, Chronic (12)  ·  Hematoma, Subdural (2)  ·  Atrial Fibrillation (1)  ·  Atrial Flutter (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Intracranial Hemorrhage, Hypertensive (1)  ·  Intracranial Hemorrhages (1)  ·  Recurrence (1)  ·  Retrognathia (1)  ·  Subarachnoid Hemorrhage (1)  ·  Wounds and Injuries (1)

Broader conditions

Hemorrhage (17)  ·  Pathologic Processes (17)  ·  Pathological Conditions, Signs and Symptoms (17)  ·  Brain Diseases (14)  ·  Cardiovascular Diseases (14)  ·  Central Nervous System Diseases (14)  ·  Cerebrovascular Disorders (14)  ·  Craniocerebral Trauma (14)  ·  Intracranial Hemorrhage, Traumatic (14)  ·  Nervous System Diseases (14)  ·  Trauma, Nervous System (14)  ·  Vascular Diseases (14)  ·  Wounds and Injuries (14)  ·  Intracranial Hemorrhages (13)

Interventions

Tranexamic Acid (7)  ·  Dabigatran (2)  ·  Dexamethasone (2)  ·  Rivaroxaban (2)  ·  apixaban (2)  ·  Acenocoumarol (1)  ·  Adrenal Cortex Hormones (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Atorvastatin (1)  ·  Calcium Dobesilate (1)  ·  Methylprednisolone (1)  ·  Phenindione (1)  ·  Prednisone (1)  ·  Saline Solution (1)  ·  Tablets (1)

Sponsors

Unity Health Toronto (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1)  ·  Chinese University of Hong Kong (1)  ·  Institut de Terapia Regenerativa Tissular (1)  ·  Kwong Wah Hospital (1)  ·  Oslo University Hospital (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  Rennes University Hospital (1)  ·  St. Olavs Hospital (1)  ·  University Hospital, Lille (1)  ·  University Hospital, Montpellier (1)  ·  University of Calgary (1)  ·  University of Edinburgh (1)  ·  University of Rostock (1)

Countries

Canada (5)  ·  France (3)  ·  China (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  India (1)  ·  Israel (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Chandrashekhar Gendle, MD PhD (1)  ·  David Birnie, MD (1)  ·  David Mathieu, M.D. (1)  ·  Elsa Jozefowicz, MD (1)  ·  Jeff Healey, MD (1)  ·  Jennifer De Jong (1)  ·  Lonjon Nicolas, MD,PhD (1)  ·  Mattis A Madsbu, MD PhD (1)  ·  Michael D Cusimano, MD, PhD (1)  ·  Milo Stanisic (1)  ·  Rustam Al-Shahi Salman, MA PhD FRCP (1)

Results publications

PMID 27150916, PMID 28583162, PMID 30462279, PMID 31610718, PMID 33787345, PMID 34022170, PMID 34465477, PMID 34487722, PMID 35042560, PMID 36700520, PMID 41999149, PMID 42423601

NIH funding

2015 (2), 2009 (1), 2016 (1), 2017 (1)